NCT04475133

Brief Summary

Echography guided percutaneous neuromodulation is a physical therapy technique, whose main objective is the treatment of pain with direct stimulation of the peripheral nerves using a rome needle of acupuncture as an active electrode for applying currents of electrostimulation. The neurophysiological basis and the effects on the sensory and motor systems of this technique are not characterised. The present study proposes to perform the intervention on the area adjacent to the median nerve and to apply different stimulation protocols on healthy subjects to answer those questions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 17, 2020

Completed
27 days until next milestone

Study Start

First participant enrolled

August 13, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 29, 2020

Completed
Last Updated

February 2, 2022

Status Verified

January 1, 2022

Enrollment Period

3 months

First QC Date

July 8, 2020

Last Update Submit

January 19, 2022

Conditions

Keywords

Echography guided percutaneous neuromodulationPlasticitysomatomotor systemPeripheral nerve stimulationPain

Outcome Measures

Primary Outcomes (24)

  • Mechanical Threshold elicited with Von Frey Filaments

    We use Von Frey Filaments of increasing caliber to make pression in the evaluated areas. When the test subject reports perception of mechanical sensation, that caliber is considered the pressure threshold to elicit mechanical. The test is performed with subject's eyes closed

    Pre-intervention / baseline

  • Mechanical Threshold elicited with Von Frey Filaments

    We use Von Frey Filaments of increasing caliber to make pression in the evaluated areas. When the test subject reports perception of mechanical sensation, that caliber is considered the pressure threshold to elicit mechanical. The test is performed with subject's eyes closed.

    Immediately after the intervention

  • Mechanical Threshold elicited with Von Frey Filaments

    We use Von Frey Filaments of increasing caliber to make pression in the evaluated areas. When the test subject reports perception of mechanical sensation, that caliber is considered the pressure threshold to elicit mechanical. The test is performed with subject's eyes closed.

    24 hours after the intervention

  • Pinprick pain threshold elicited with Von Frey Filaments

    We use Von Frey Filaments of increasing caliber to make pression in the evaluated areas. When the test subject reports perception of pinprick sensation, that caliber is considered the pressure threshold to elicit pinprick pain. The test is performed with subject's eyes closed

    pre-intervention / baseline

  • Pinprick pain threshold elicited with Von Frey Filaments

    We use Von Frey Filaments of increasing caliber to make pression in the evaluated areas. When the test subject reports perception of pinprick sensation, that caliber is considered the pressure threshold to elicit pinprick pain. The test is performed with subject's eyes closed

    Immediately after the intervention

  • Pinprick pain threshold elicited with Von Frey Filaments

    We use Von Frey Filaments of increasing caliber to make pression in the evaluated areas. When the test subject reports perception of pinprick sensation, that caliber is considered the pressure threshold to elicit pinprick pain. The test is performed with subject's eyes closed

    24 hours after the intervention

  • Pain evocated with Von Frey Filaments.

    We use Von Frey Filaments of increasing caliber to make pression with 100g, 180g and 300g in the evaluated areas. Each filament to make pression three times. The subject reports the pain in a scale of 0-10 number (scale NSR: 0 is any pain and 10 is the maximal perception of pain. The test is performed with subject's eyes closed.

    Pre-intervention / baseline

  • Pain evocated with Von Frey Filaments.

    We use Von Frey Filaments of increasing caliber to make pression with 100g, 180g and 300g in the evaluated areas. Each filament to make pression three times. The subject reports the pain in a scale of 0-10 number (scale NSR: 0 is any pain and 10 is the maximal perception of pain. The test is performed with subject's eyes closed.

    Immediately after the intervention

  • Pain evocated with Von Frey Filaments.

    We use Von Frey Filaments of increasing caliber to make pression with 100g, 180g and 300g in the evaluated areas. Each filament to make pression three times. The subject reports the pain in a scale of 0-10 number (scale NSR: 0 is any pain and 10 is the maximal perception of pain. The test is performed with subject's eyes closed.

    24 hours after the intervention

  • Pressure pain threshold with algometer.

    On the marked areas we make pressure with pressure algometer. When the subject experiences any sense of pain, he/she has to say "stop" and immediately the algometer was removed. The number in Kg marked by the algometer is annotated. The mean of two measurements was taken for analysis. The second measurement was taken with a minimum of 30 seconds after the previous one.

    pre-intervention / baseline

  • Change in pressure pain threshold with algometer.

    On the marked areas we make pressure with pressure algometer. When the subject experiences any sense of pain, he/she has to say "stop" and immediately the algometer was removed. The number in Kg marked by the algometer is annotated. The mean of two measurements was taken for analysis. The second measurement was taken with a minimum of 30 seconds after the previous one.

    Immediately after the intervention

  • Change in pressure pain threshold with algometer.

    On the marked areas we make pressure with pressure algometer. When the subject experiences any sense of pain, he/she has to say "stop" and immediately the algometer was removed. The number in Kg marked by the algometer is annotated. The mean of two measurements was taken for analysis. The second measurement was taken with a minimum of 30 seconds after the previous one.

    24 hours after the intervention

  • Maximum grip force with dynamometer

    The subject is standing with the dynamometer in his hand. He/she must press the dynamometer during 5 second, 3 times with 30 seconds to rest between them.

    pre-intervention / baseline

  • Change in maximum grip force with dynamometer

    The subject is standing with the dynamometer in his hand. He/she must press the dynamometer during 5 second, 3 times with 30 seconds to rest between them.

    Immediately after the intervention

  • Change in maximum grip force with dynamometer.

    The subject is standing with the dynamometer in his hand. He/she must press the dynamometer during 5 second, 3 times with 30 seconds to rest between them.

    24 hours after the intervention

  • Maximum grip force with surface electromyography.

    The subject is standing with the dynamometer in his hand. He/she must press the dynamometer during 5 second, 3 times with 30 seconds to rest between them.

    pre-intervention / baseline

  • Change in maximum grip force with surface electromyography.

    The subject is standing with the dynamometer in his hand. He/she must press the dynamometer during 5 second, 3 times with 30 seconds to rest between them.

    Immediately after the intervention

  • Change in maximum grip force with surface electromyography.

    The subject is standing with the dynamometer in his hand. He/she must press the dynamometer during 5 second, 3 times with 30 seconds to rest between them.

    24 hours after the intervention

  • Arterial peak systolic velocity with Color Doppler Ultrasonography

    On the marked areas (Brachial ipsilateral and contralateral, radial and ulnar arteries) we measure the arterial peak systolic during 5 cardiac cycles.

    pre-intervention / baseline

  • Change in arterial peak systolic velocity with Color Doppler Ultrasonography in placebo group

    In placebo group, on the marked areas (Brachial ipsilateral and contralateral, radial and ulnar arteries) we measure the arterial peak systolic during 5 cardiac cycles inmediately after introduce the needly in the arm.

    Immediately after the needle insertion

  • Change in arterial peak systolic velocity with Color Doppler Ultrasonography

    On the marked areas (Brachial ipsilateral and contralateral, radial and ulnar arteries) we measure the arterial peak systolic during 5 cardiac cycles.

    Immediately after the intervention

  • Arterial volume flow with Color Doppler Ultrasonography

    On the marked areas (Brachial ipsilateral and contralateral, radial and ulnar arteries) we measure the arterial volume flow during 5 cardiac cycles.

    pre-intervention / baseline

  • Change in arterial volume flow with Color Doppler Ultrasonography

    In placebo group, on the marked areas (Brachial ipsilateral and contralateral, radial and ulnar arteries) we measure the arterial volume flow during 5 cardiac cycles.

    Immediately after the needle insertion

  • Change in arterial volume flow with Color Doppler Ultrasonography

    On the marked areas (Brachial ipsilateral and contralateral, radial and ulnar arteries) we measure the arterial volume flow during 5 cardiac cycles.

    Immediately after the intervention

Secondary Outcomes (30)

  • Electric current threshold of perception with low frequency

    pre-intervention / baseline

  • Change in Electric current threshold of perception with low frequency

    Immediately after the intervention

  • Change in Electric current threshold of perception with low frequency

    24 hours after the intervention

  • Electric current threshold of perception with high frequency

    pre-intervention / baseline

  • Change electric current threshold of perception with high frequency

    Immediately after the intervention

  • +25 more secondary outcomes

Study Arms (3)

Low-frequency and high-intensity

EXPERIMENTAL

The intervention of ultrasound guided percutaneous neuromodulation is applied over the median nerve. The parameters are continuous stimulation of low frequency (2 hz) and high intensity (slightly painful) during 16 minutes.

Other: Ultrasound guided percutaneous neuromodulation

High-frequency and low-intensity

EXPERIMENTAL

The intervention of ultrasound guided percutaneous neuromodulation is applied over the median nerve. The parameters are high frequency (100 hz) and low intensity trains. There are 5 trains, 5 second active current and 55 second without current per train. The current is off on the first 11 minutes and the next 5 minutes it will be on. The total time is 16 minutes.

Other: Ultrasound guided percutaneous neuromodulation

Control group

SHAM COMPARATOR

The intervention of ultrasound guided percutaneous neuromodulation is applied over the median nerve without current during 16 minutes.

Other: Ultrasound guided percutaneous neuromodulation

Interventions

It is a technique that consists in the electrical stimulation of peripheral nerve trunks, inserting an acupuncture needle in its path and using it as an electrode to apply electrical current

Control groupHigh-frequency and low-intensityLow-frequency and high-intensity

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy.
  • more than 18 years old
  • amateur athlete.

You may not qualify if:

  • to suffer or to have suffered any pathology on the arm on the last 30 days.
  • to suffer some disease discouraging current application or needle¡ing, as coagulation deficit, etc.
  • to suffer some disease as diabetes mellitus, cancer, neurology disease, depression, fibromyalgia, etc.
  • to consume drugs as coagulants, anti-depressant, pregabalin, etc during investigation or the first week before investigation.
  • to consume nsaids the last 48 hours before investigation or during investigation.
  • to consume opioids the first week before investigation or during investigation.
  • belonephobia.
  • professional athlete
  • to be pregnant
  • to suffer immunodepression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Francisco Ortega Rehabilitación Avanzada, S.L.

Elche, Alicante, 03203, Spain

Location

Related Publications (50)

  • Wilson RD, Harris MA, Gunzler DD, Bennett ME, Chae J. Percutaneous peripheral nerve stimulation for chronic pain in subacromial impingement syndrome: a case series. Neuromodulation. 2014 Dec;17(8):771-6; discussion 776. doi: 10.1111/ner.12152. Epub 2014 Feb 11.

    PMID: 24512114BACKGROUND
  • Toprak U, Selvi NA, Ates A, Erhuner Z, Bostanoglu S, Karademir MA, Karaaslan Y. Dynamic Doppler evaluation of the hand arteries of the patients with Raynaud's disease. Clin Rheumatol. 2009 Jun;28(6):679-83. doi: 10.1007/s10067-009-1131-1. Epub 2009 Feb 24.

    PMID: 19238503BACKGROUND
  • Barlas P, Ting SL, Chesterton LS, Jones PW, Sim J. Effects of intensity of electroacupuncture upon experimental pain in healthy human volunteers: a randomized, double-blind, placebo-controlled study. Pain. 2006 May;122(1-2):81-9. doi: 10.1016/j.pain.2006.01.012. Epub 2006 Mar 9.

  • Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993 Jan 7;361(6407):31-9. doi: 10.1038/361031a0.

  • Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973 Jul;232(2):331-56. doi: 10.1113/jphysiol.1973.sp010273.

  • Borg-Stein J, Simons DG. Focused review: myofascial pain. Arch Phys Med Rehabil. 2002 Mar;83(3 Suppl 1):S40-7, S48-9. doi: 10.1053/apmr.2002.32155.

  • Chae J, Wilson RD, Bennett ME, Lechman TE, Stager KW. Single-lead percutaneous peripheral nerve stimulation for the treatment of hemiplegic shoulder pain: a case series. Pain Pract. 2013 Jan;13(1):59-67. doi: 10.1111/j.1533-2500.2012.00541.x. Epub 2012 Mar 26.

  • Chapman CR, Gavrin J. Suffering: the contributions of persistent pain. Lancet. 1999 Jun 26;353(9171):2233-7. doi: 10.1016/S0140-6736(99)01308-2.

  • Chan AW, MacFarlane IA, Bowsher D, Campbell JA. Weighted needle pinprick sensory thresholds: a simple test of sensory function in diabetic peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1992 Jan;55(1):56-9. doi: 10.1136/jnnp.55.1.56.

  • Corneil BD, Goonetilleke SC, Peel TR, Green KA, Welch ID. Ultrasound-guided insertion of intramuscular electrodes into suboccipital muscles in the non-human primate. J Electromyogr Kinesiol. 2012 Aug;22(4):553-9. doi: 10.1016/j.jelekin.2012.02.014. Epub 2012 Mar 22.

  • Dommerholt J. Dry needling - peripheral and central considerations. J Man Manip Ther. 2011 Nov;19(4):223-7. doi: 10.1179/106698111X13129729552065.

  • Domingo A, Mayoral O, Monterde S, Santafe MM. Neuromuscular damage and repair after dry needling in mice. Evid Based Complement Alternat Med. 2013;2013:260806. doi: 10.1155/2013/260806. Epub 2013 Apr 9.

  • Dubuisson D. Effect of dorsal-column stimulation on gelatinosa and marginal neurons of cat spinal cord. J Neurosurg. 1989 Feb;70(2):257-65. doi: 10.3171/jns.1989.70.2.0257.

  • Falowski S, Celii A, Sharan A. Spinal cord stimulation: an update. Neurotherapeutics. 2008 Jan;5(1):86-99. doi: 10.1016/j.nurt.2007.10.066.

  • Finnerup NB, Sindrup SH, Jensen TS. Recent advances in pharmacological treatment of neuropathic pain. F1000 Med Rep. 2010 Jul 14;2:52. doi: 10.3410/M2-52.

  • Foreman RD, Linderoth B. Neural mechanisms of spinal cord stimulation. Int Rev Neurobiol. 2012;107:87-119. doi: 10.1016/B978-0-12-404706-8.00006-1.

  • Fruhstorfer H, Gross W, Selbmann O. von Frey hairs: new materials for a new design. Eur J Pain. 2001;5(3):341-2. doi: 10.1053/eujp.2001.0250.

  • Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev. 2009 Apr;60(1):214-25. doi: 10.1016/j.brainresrev.2008.12.009. Epub 2008 Dec 25.

  • Kalra A, Urban MO, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther. 2001 Jul;298(1):257-63.

  • Kendall NA. Psychosocial approaches to the prevention of chronic pain: the low back paradigm. Baillieres Best Pract Res Clin Rheumatol. 1999 Sep;13(3):545-54. doi: 10.1053/berh.1999.0044.

  • MENDELL LM, WALL PD. RESPONSES OF SINGLE DORSAL CORD CELLS TO PERIPHERAL CUTANEOUS UNMYELINATED FIBRES. Nature. 1965 Apr 3;206:97-9. doi: 10.1038/206097a0. No abstract available.

  • Klein T, Magerl W, Hopf HC, Sandkuhler J, Treede RD. Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. J Neurosci. 2004 Jan 28;24(4):964-71. doi: 10.1523/JNEUROSCI.1222-03.2004.

  • Kregel J, van Wilgen CP, Zwerver J. Pain assessment in patellar tendinopathy using pain pressure threshold algometry: an observational study. Pain Med. 2013 Nov;14(11):1769-75. doi: 10.1111/pme.12178. Epub 2013 Jun 26.

  • Ng DT, Spear ED, Walter P. The unfolded protein response regulates multiple aspects of secretory and membrane protein biogenesis and endoplasmic reticulum quality control. J Cell Biol. 2000 Jul 10;150(1):77-88. doi: 10.1083/jcb.150.1.77.

  • Ochoa JL. Pain mechanisms in neuropathy. Curr Opin Neurol. 1994 Oct;7(5):407-14. doi: 10.1097/00019052-199410000-00008.

  • Randic M, Jiang MC, Cerne R. Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord. J Neurosci. 1993 Dec;13(12):5228-41. doi: 10.1523/JNEUROSCI.13-12-05228.1993.

  • Sdrulla AD, Xu Q, He SQ, Tiwari V, Yang F, Zhang C, Shu B, Shechter R, Raja SN, Wang Y, Dong X, Guan Y. Electrical stimulation of low-threshold afferent fibers induces a prolonged synaptic depression in lamina II dorsal horn neurons to high-threshold afferent inputs in mice. Pain. 2015 Jun;156(6):1008-1017. doi: 10.1097/01.j.pain.0000460353.15460.a3.

  • Sjolund B. The ventral spino-olivocerebellar system in the cat. V. Supraspinal control of spinal transmission. Exp Brain Res. 1978 Nov 15;33(3-4):509-22. doi: 10.1007/BF00235571.

  • RaviChandran N, Aw KC, McDaid A. Characterizing the Motor Points of Forearm Muscles for Dexterous Neuroprostheses. IEEE Trans Biomed Eng. 2020 Jan;67(1):50-59. doi: 10.1109/TBME.2019.2907926. Epub 2019 Mar 28.

  • Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2006 Jan;10(1):77-88. doi: 10.1016/j.ejpain.2005.02.003.

  • Russo CM, Brose WG. Chronic pain. Annu Rev Med. 1998;49:123-33. doi: 10.1146/annurev.med.49.1.123.

  • Svendsen F, Rygh LJ, Gjerstad J, Fiska A, Hole K, Tjolsen A. Recording of long-term potentiation in single dorsal horn neurons in vivo in the rat. Brain Res Brain Res Protoc. 1999 Jul;4(2):165-72. doi: 10.1016/s1385-299x(99)00018-5.

  • Sandkuhler J. Learning and memory in pain pathways. Pain. 2000 Nov;88(2):113-118. doi: 10.1016/S0304-3959(00)00424-3. No abstract available.

  • Sandkuhler J, Liu X. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. Eur J Neurosci. 1998 Jul;10(7):2476-80. doi: 10.1046/j.1460-9568.1998.00278.x.

  • Schaible HG. Peripheral and central mechanisms of pain generation. Handb Exp Pharmacol. 2007;(177):3-28. doi: 10.1007/978-3-540-33823-9_1.

  • Shay BL, Hochman S. Serotonin alters multi-segmental convergence patterns in spinal cord deep dorsal horn and intermediate laminae neurons in an in vitro young rat preparation. Pain. 2002 Jan;95(1-2):7-14. doi: 10.1016/s0304-3959(01)00364-5.

  • Sivilotti LG, Thompson SW, Woolf CJ. Rate of rise of the cumulative depolarization evoked by repetitive stimulation of small-caliber afferents is a predictor of action potential windup in rat spinal neurons in vitro. J Neurophysiol. 1993 May;69(5):1621-31. doi: 10.1152/jn.1993.69.5.1621.

  • Smits H, van Kleef M, Holsheimer J, Joosten EA. Experimental spinal cord stimulation and neuropathic pain: mechanism of action, technical aspects, and effectiveness. Pain Pract. 2013 Feb;13(2):154-68. doi: 10.1111/j.1533-2500.2012.00579.x. Epub 2012 Jul 11.

  • Somers DL, Clemente FR. Contralateral high or a combination of high- and low-frequency transcutaneous electrical nerve stimulation reduces mechanical allodynia and alters dorsal horn neurotransmitter content in neuropathic rats. J Pain. 2009 Feb;10(2):221-9. doi: 10.1016/j.jpain.2008.08.008. Epub 2008 Nov 17.

  • Stevanato G, Devigili G, Eleopra R, Fontana P, Lettieri C, Baracco C, Guida F, Rinaldo S, Bevilacqua M. Chronic post-traumatic neuropathic pain of brachial plexus and upper limb: a new technique of peripheral nerve stimulation. Neurosurg Rev. 2014 Jul;37(3):473-79; discussion 479-80. doi: 10.1007/s10143-014-0523-0. Epub 2014 Feb 21.

  • Telles JD, Gabanela Schiavon MA, Rampazo da Silva EP, Liebano RE. Transcutaneous electrical nerve stimulation and cervical joint manipulation on pressure pain threshold. Pain Manag. 2018 Jul 1;8(4):263-269. doi: 10.2217/pmt-2017-0069. Epub 2018 Jun 1.

  • Treede RD. Gain control mechanisms in the nociceptive system. Pain. 2016 Jun;157(6):1199-1204. doi: 10.1097/j.pain.0000000000000499.

  • Tompra N, van Dieen JH, Coppieters MW. Central pain processing is altered in people with Achilles tendinopathy. Br J Sports Med. 2016 Aug;50(16):1004-7. doi: 10.1136/bjsports-2015-095476. Epub 2015 Dec 23.

  • Von Frey M (1896). Untersuchung und ̈ber die Sinnesfunktionen der menschlichen Haut. Erste Abhandlung: Druckempfindung und Schmerz. Abhandlungen der mathematischphysischen Klasse der Königlichen Sa ̈chsischen Gesellschaft der Wissenschaften;. p. 23.

    RESULT
  • Weinstein S (1968). Intensive and extensive aspects of tactile sensitivity as a function of body part, sex, and laterality. In: Kenshalo D, Springfield R, Thomas C, editors. The skin senses. p. 195- 222.

    RESULT
  • Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011 Mar;152(3 Suppl):S2-S15. doi: 10.1016/j.pain.2010.09.030. Epub 2010 Oct 18.

  • Yang F, Zhang C, Xu Q, Tiwari V, He SQ, Wang Y, Dong X, Vera-Portocarrero LP, Wacnik PW, Raja SN, Guan Y. Electrical stimulation of dorsal root entry zone attenuates wide-dynamic-range neuronal activity in rats. Neuromodulation. 2015 Jan;18(1):33-40; discussion 40. doi: 10.1111/ner.12249. Epub 2014 Oct 10.

  • Ylinen J. Pressure algometry. Aust J Physiother. 2007;53(3):207. doi: 10.1016/s0004-9514(07)70032-6. No abstract available.

  • Shacklock M. (2007). Neurodinámica clínica: un nuevo sistema de tratamiento musculoesquelético. Madrid: Elsevier.

    RESULT
  • Amer-Cuenca, J. J. (2010). Programación y aplicación de la estimulación nerviosa eléctrica transcutánea (TENS): guía de práctica clínica basada en la evidencia. Fisioterapia, 32(6), 271-278.

    RESULT

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Patricia Beltrá López

    Clínica Francisco Javier Ortega Puebla

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Order of treatments was randomized by a third person not involved in any of the other phases. Also, after the care provider has inserted the needle in the three groups, another third person without involvement in any other phase of the study choose the assigned treatment between three pre-programmed closed set of parameters in the stimulation machine, thus leaving treatment unknown for the care provider, the participant, the investigator and the outcome assessor, which received only encoded names for the groups.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized intervention of repeated measures, quadruple-blinded
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2020

First Posted

July 17, 2020

Study Start

August 13, 2020

Primary Completion

October 29, 2020

Study Completion

October 29, 2020

Last Updated

February 2, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations